Spectral AI Inc. Market Cap ($46.65 Million)
Market Cap & Net Worth: Spectral AI Inc. (MDAI)
Spectral AI Inc. market cap. Spectral AI Inc. (NASDAQ:MDAI) has a market capitalization of $46.65 Million ($46.65 Million) as of November 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #21982 globally and #4900 in its home market, demonstrating a 5.56% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Spectral AI Inc.'s stock price $1.52 by its total outstanding shares 30688895 (30.69 Million). Also see MDAI cash generation efficiency for how efficiently the company converts equity into cash flow.
Spectral AI Inc. Market Cap History (2021–2026)
Spectral AI Inc. market cap history from 2021 to 2026. Data shows change from $301.06 Million to $46.65 Million (-28.27% CAGR). Check Spectral AI Inc. stock quote for real-time trading data and today's change.
Index Memberships
Spectral AI Inc. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.60 Trillion | 0.00% | #624 of 976 |
|
NASDAQ Composite
IXIC
|
$39.84 Trillion | 0.00% | #2077 of 3165 |
Weight: Spectral AI Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Spectral AI Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Spectral AI Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Spectral AI Inc. growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.94x
Spectral AI Inc.'s market cap is 2.94 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $301.06 Million | $15.24 Million | -$3.99 Million | 19.76x | N/A |
| 2022 | $309.96 Million | $25.37 Million | -$2.91 Million | 12.22x | N/A |
| 2023 | $75.49 Million | $18.06 Million | -$20.85 Million | 4.18x | N/A |
| 2024 | $86.85 Million | $29.58 Million | -$15.31 Million | 2.94x | N/A |
Competitor Companies of MDAI by Market Capitalization
Companies near Spectral AI Inc. in the global market cap rankings as of November 3, 2026. Also see Spectral AI Inc. (MDAI) total assets for a full breakdown of the balance sheet.
Key companies related to Spectral AI Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $191.55 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $117.68 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #227 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $191.55 Billion | $110.16 |
| #204 | Stryker Corporation | NYSE:SYK | $117.68 Billion | $306.81 |
| #227 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $99.29 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Spectral AI Inc. (2021–2026)
Market capitalization of Spectral AI Inc. from 2021 to today. Between 2021 and today, Spectral AI Inc.'s market cap moved from $301.06 Million to $ 46.65 Million, with a yearly change of -28.27%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $46.65 Million | +7.04% |
| 2025 | $43.58 Million | -49.82% |
| 2024 | $86.85 Million | +15.04% |
| 2023 | $75.49 Million | -75.64% |
| 2022 | $309.96 Million | +2.96% |
| 2021 | $301.06 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Spectral AI Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $46.65 Million USD |
| MoneyControl | $46.65 Million USD |
| MarketWatch | $46.65 Million USD |
| marketcap.company | $46.65 Million USD |
| Reuters | $46.65 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Spectral AI Inc.
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary predic… Read more